Latest Chronic Pruritus Stories
CANTERBURY, England, March 19, 2015 /PRNewswire/ -- - Prestigious peer-review journal accepts paper demonstrating a reduction of pruritus (itch)
-- Statistically Significant Data from Phase 2 Study Support Safety and Efficacy of Once Daily Dosing of NK-1 Antagonist, VPD-737 (serlopitant) SOUTH SAN FRANCISCO, Calif., Dec.
CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.